| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |